Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-09
2011-08-09
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S326000, C514S330000, C546S192000, C546S207000, C546S213000, C546S216000
Reexamination Certificate
active
07994195
ABSTRACT:
Compounds comprisingor a pharmaceutically acceptable salt or a prodrug thereof are disclosed herein. Details are provided herein. Compositions, methods, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 6552067 (2003-04-01), Cameron et al.
patent: 6586468 (2003-07-01), Maruyama et al.
patent: 6747037 (2004-06-01), Old et al.
patent: 6763702 (2004-07-01), Chien et al.
patent: 2004/0142969 (2004-07-01), Elworthy
patent: 2004/0198701 (2004-10-01), Billot et al.
patent: WO2004/063158 (2004-07-01), None
patent: WO2004/085430 (2004-10-01), None
U.S. Appl. No. 60/577,361, filed Jun. 4, 2004, Old, et al.
U.S. Appl. No. 10/861,951, filed Jun. 3, 2004, Old, et al.
Burk Robert M.
Old David W.
Allergan Inc.
Anderson Rebecca
Forrestal Kevin J.
Shterengarts Samantha
Wurst John E.
LandOfFree
Therapeutic substituted piperidone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic substituted piperidone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic substituted piperidone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2736894